Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFTRIAXONE vs CEMIPLIMAB-RWLC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFTRIAXONE vs CEMIPLIMAB-RWLC: Safety Overview

Metric CEFTRIAXONE CEMIPLIMAB-RWLC
Total FAERS Reports 19,418 1,554
Deaths Reported 2,926 323
Death Rate 15.1% 20.8%
Hospitalizations 9,596 441
Average Patient Age 55.8 yrs 70.2 yrs
% Female Patients 47.2% 40.6%
FDA Approval Date Apr 12, 2007 N/A
Manufacturer Baxter Healthcare Company N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Prescription